Abstract-In the vasculature, reactive oxygen species (ROS) generated by both mitochondrial respiration and enzymatic sources serve as integral components of cellular signaling and homeostatic mechanisms. Because ROS are highly reactive biomolecules, the cellular redox milieu is carefully maintained by small-molecule antioxidants and antioxidant enzymes to prevent the deleterious consequences of ROS excess. When this redox balance is perturbed, because of either increased ROS production or decreased antioxidant capacity, oxidant stress is increased in the vessel wall and, if not offset, vascular dysfunction ensues. A number of heritable polymorphisms of pro-oxidant enzymes, including 5-lipoxygenase, cyclooxygenase-2, nitric oxide synthase-3, and NAD(P)H oxidase, have been identified and found to modulate ROS production and, thereby, the risk of atherothrombotic cardiovascular disease in individuals with these genetic polymorphisms. Similarly, heritable deficiency of the antioxidant enzymes catalase, glutathione peroxidases, glutathione-S-transferases, heme oxygenase, and glucose-6-phosphate dehydrogenase favors ROS accumulation, and has been associated with an increased risk of vascular disease. Individually, each of these polymorphisms imposes a state of uncompensated oxidant stress on the vasculature and collectively comprise the oxidative enzymopathies. Key Words: antioxidants Ⅲ atherosclerosis Ⅲ genetic polymorphism Ⅲ reactive oxygen species C ellular respiration in an oxygen-rich environment generates abundant derivatives of partially reduced oxygen, collectively termed reactive oxygen species (ROS). Under basal conditions, ROS serve as an integral component of cellular signaling pathways; however, when these highly reactive metabolic products are in excess, they impose an oxidant stress on the cellular environment, which, in turn, modifies biomolecules to modulate cell and organism phenotype. 1 To protect against cellular oxidant stress and its adverse sequelae, adaptive enzymatic mechanisms have evolved to metabolize ROS into less reactive forms and minimize their potential to produce oxidative damage and cellular dysfunction.The importance of maintaining a balance between ROS production and metabolism is highlighted when there is deficiency or dysfunction of vascular antioxidant enzymes. This results in a net accumulation of ROS because of decreased antioxidant capacity in the setting of ambient ROS production by vascular sources. Recent interest has focused on heritable polymorphisms of vascular antioxidant enzymes as one mechanism by which antioxidant capacity is diminished. These polymorphisms have been associated with an increased risk of vascular disease in both animal models and human studies and collectively may be recognized as oxidative enzymopathies.
Vascular Sources of ROSUnder basal conditions, superoxide anion, a 1-electron reduction product of oxygen, is the primary source from which Original